The cellular prion protein (PrP C ) is best known for its misfolded disease-causing conformer, PrP Sc . Because the availability of PrP C is often limiting for prion propagation, understanding its regulation may point to possible therapeutic targets. We sought to determine to what extent the human microRNAome is involved in modulating PrP C levels through direct or indirect pathways. We probed PrP C protein levels in cells subjected to a genome-wide library encompassing 2019 miRNA mimics using a robust time-resolved fluorescence-resonance screening assay. Screening was performed in three human neuroectodermal cell lines: U-251 MG, CHP-212 and SH-SY5Y. The three screens yielded 17 overlapping high-confidence miRNA mimic hits, 13 of which were found to regulate PrP C biosynthesis directly via binding to the PRNP 3'UTR, thereby inducing transcript degradation. The four remaining hits (miR-124-3p, 192-3p, 299-5p and 376b-3p) did not bind either the 3'UTR or CDS of PRNP, and were therefore deemed indirect regulators of PrP C . Our results show that multiple miRNAs regulate PrP C levels both directly and indirectly. These findings may have profound implications for prion disease pathogenesis and potentially also for their therapy. Furthermore, the possible role of PrP C as a mediator of Aβ toxicity suggests that its regulation by miRNAs may also impinge on Alzheimer's disease.
INTRODUCTION
Prion diseases are characterized by misfolding and aggregation of the cellular prion protein (PrP C ) into its pathogenic conformer, PrP Sc (42) . Despite significant advances in exposing the physiological roles of PrP C and in elucidating mechanisms underlying PrP Sc -induced toxicity, the molecular machinery controlling spatiotemporal PrP C expression remains unexplored.
Over the past decade, microRNAs (miRNA) have emerged as important biomarkers and micro-modulators of numerous biological processes ranging from development to disease (19) . These roughly 22 nucleotide non-coding RNAs predominantly regulate protein expression levels post-transcriptionally by repressing and/or degrading an estimated 60% of all human protein-coding transcripts (16) . miRNAs function by associating with Argonaute (AGO) proteins to form a mature miRNA-induced silencing complex (miRISC). While four human AGO proteins have been described, only AGO2 possesses endonucleolytic activity (31) . miRNAs guide the miRISC to targets by typically binding their 2-8 nucleotide "seed sites" to complementary mRNA 3′ untranslated regions (3′UTRs) (22) . Comprehensive analysis of miRNA interaction sites in human brains using Argonaute cross-linking immunoprecipitation (AGO-CLIP) has revealed that 41% of these sites reside in 3′UTRs, while coding sequences (CDS), intronic regions and 5′ untranslated regions (5′UTR) make up the other 40%, 15% and 1%, respectively (9) .
Several miRNAs, most notably miR-124-3p, miR-146a-5p and miR-342-3p, have been found to become consistently deregulated following prion infection in GT1-7 neuronal cells (7) , RML inoculation in mice (39, 40) , scrapie infection in sheep (41) , BSE infection in macaques (33) and sporadic Creutzfeldt-Jakob disease (sCJD) in humans (25) . These miRNAs also display similar spatiotemporal expression patterns during prion disease pathogenesis (8, 27) and in sCJD subtypes (23) , implying that mechanisms of deregulation may be conserved across species. Intriguingly, miR-124-3p, which is highly expressed in almost all brain regions (44) , has also been found to be downregulated in the brains of patients suffering from Alzheimer's (24) and Huntington's disease (18) . These data collectively qualify miRNAs as potential biomarkers and as possible regulators of the pathogenic process in transmissible spongiform encephalopathies (TSE). It has also been reported once (but never confirmed) that human PrP C binds AGO, and in doing so promotes the formation and stabilization of miRISC (17) . However, it remains unknown to what extent, miRNAs might play a part in regulating PrP C expression levels. As suppression of PrP C by shRNA can abrogate PrP Sc accumulation and prolongs survival of scrapieinfected mice (37) , identification of endogenous PrP C modulators may provide a therapeutic avenue for TSEs.
Several miRNA target prediction tools exist that calculate likeliness of miRNA binding to transcripts through assessing their thermodynamic stability and conserved seed region complementarity in 3'UTR (1) and CDS (38) . Yet, these estimates remain tentative due to their high degree of false positives. AGO-CLIP offers a more biologically accurate compendium of miRNA-bound target sites. However, as these data are predominantly generated via AGO2 immunoprecipitation, the recovered hits correspond mostly to endonucleolytically cleaved transcripts (31) , whereas the pleiotropic interplay between other AGO proteins is not reflected in CLIP data (43) . Furthermore, miRNA-AGO associations do not necessarily imply functional downstream effects. Accordingly, a comparison of miRNA transfection and AGO-CLIP data revealed an overlap between miRNA targets detected by the two approaches, but found that CLIP was not strongly predictive of target expression changes (45) . Cell-based screenings can address the limitations of target detection techniques by assessing functionality of canonical, non-canonical and indirect regulators.
The current study aims to examine the degree to which the human microRNAome affects PrP C expression, and determine whether PrP C -regulating miRNAs function through direct or indirect pathways. Toward this goal, we developed a robust high-throughput arrayed screen, employing a genome-wide miRNA library. This exploratory approach was able to exhaustively analyze miRNA-induced changes in PrP C , some of which were previously predicted by target interaction estimates, whereas others are entirely novel. These findings may acquire medical significance in view of the requirement for PrP C in development of prion diseases (12, 13) and its presumed, albeit controversial, role in mediating Aβ toxicity in Alzheimer's disease (14, 21) .
METHODS

Cell lines
A homozygous frameshift mutation was generated in the PRNP locus of SH-SY5Y (ATCC) using the CRISPRCas9 system to delete the second adenine in the third codon of the PRNP CDS (chr20: 4,699,229), located in exon 2. This was achieved by designing a sgRNA that bound in close proximity to the PRNP start codon. This sgRNA was cloned into a MLM3636 expression vector and transfected into SH-SY5Y wt cells alongside a Cas9-2A-EGFP plasmid. 48 h after transfection, single EGFPpositive cells were sorted into a 96 well plate by single cell fluorescence-activated cell sorting. Individual clones were expanded for four weeks and screened for PRNP -/-. Clones were characterized by blunt-end PCR insertion of PRNP fragments into TOPO vectors. Sanger sequencing ( Figure S1 ) revealed that a double strand break and subsequent non-homologous end joining had induced a frameshift and a premature stop codon, resulting in a functional PrP C knockout mutant. The full-length 765bp linearized CDS region of mouse Prnp, under the control of a CMV promotor, was stably transfected and randomly integrated into these PrP C knockout cells. Following antibiotic selection, a single clone, designated SH-SY5Y M4, was expanded on the basis of high PrP C expression levels.
SH Following a 72-h incubation period at 37°C, media was removed by turning the plate upside-down and 10 uL of lysis buffer (0.5% Na deoxycholate, 0.5% Triton X, supplemented with cOmplete Mini Protease Inhibitors and 0.5% BSA (Merck)) was dispensed per well. 5 uL (2.5 nM final) POM2 or POM19 (made in-house), coupled to Europium (Eu), as previously described (4) , and diluted in 1X Lance Detection Buffer (Perkin Elmer) was dispensed for U-251 MG and CHP-212 or SH-SY5Y M4 cells, respectively. Five microliter (5 nM final) POM1 conjugated to Allophycocyanin (APC) was successively added per well for all cell types screened. TR-FRET readout was performed after a 12-h 4°C incubation using an EnVison 2105 Multimode Plate Reader (PerkinElmer) with previously defined measurement parameters (4).
Quantitative PCR
Candidate mimic PRNP mRNA levels were assessed in a follow-up U-251 MG screen. Samples were identically processed up to the point of media removal, after which a 3:1 mixture of TRIzolLS (Thermo Fisher) to media was applied to wells and mRNA was extracted according the manufacturers' protocol. QuantiTect Reverse Transcription Kit (Qiagen) was used for cDNA synthesis and qPCR was performed using FastStart Universal SYBR Green Master (Rox) (Merck, Darmstadt, Germany). Candidate mimics were run in biological triplicates and assessed for PRNP mRNA levels using GUSB, TBP and ACTB as housekeeping genes for sample normalization. HMGA2 mRNA normalized to ACTB was used as a post-inhibitor screen quality control assessment to test library efficacy, using let-7d-5p inhibitor as a presumptive positive regulator of HMGA2. All qPCR samples were run in technical triplicates in white Hard-Shell 96-Well PCR Plates (Bio-Rad) using the following primer pairs: 
Data analysis
Net FRET calculations and blank subtractions were performed as previously described (4) per plate for each mimic and inhibitor screen. Z′-Factors (Z′) were calculated across all 24 plates per screen using central controls. Sample SSMDs were derived from biological triplicates and central negative control mean and standard deviation values across four plates, among which replicas were printed. Mimic screening hit calling criteria were set at ≥5, ≤−5 for U-251 MG and ≥3, ≤−3 for both CHP-212 and SH-SY5Y M4. Inhibitor screen hit calling criteria were set at ≥1.5, ≤−1.5 for U-251 MG and CHP-212 due to overall low SSMD scores. Negative and positive controls from TR-FRET, cell viability and qPCR assays were set at 100% and 0%, respectively. Samples were normalized to this range by feature scaling. An arbitrary 10% cutoff above or below the negative control was selected as the determinant for altered PrP C , cell viability or PRNP mRNA levels. An unpaired two-tailed parametric t-test was used for calculating significance between samples for the reporter assays.
Reporter construction
The wt PRNP 3'UTR and nine mutant forms thereof (Table S1) 
RESULTS
High-throughput screen reliably detects PrP C
To identify miRNAs regulating PrP C , we performed a genomewide human miRNA screen. We assessed PrP C levels from cell lysates in single wells using a time-resolved fluorescence resonance energy transfer (TR-FRET) readout as described (4) . This allowed high-throughput arrayed screening of the entire currently available human miRNA repertoire (miRBase v.21), consisting of 2′019 mimics and 2′019 corresponding inhibitors. Screening was performed using U-251 MG glioblastoma, CHP-212 neuroblastoma and SH-SY5Y M4 neuroblastoma human cell lines ( Figure 1A ). Cell lines were selected based on high PrP C expression, as revealed by western blot ( Figure S2A ) and TR-FRET ( Figure S2B ). SH-SY5Y M4, a PRNP -/-line overexpressing the mouse Prnp CDS (see Methods), was used for the selective interrogation of non-3′UTR regulating miRNAs. Overlap of miRNA-mediated PrP C regulation in multiple cell lines allowed us to identify high-confidence hits that may be universally functional. 
A B
As RNA interference (RNAi) screens are often hampered by poor reproducibility (5), we set out to develop a highly robust assay by optimizing sample and control distributions, library concentration, transfection reagent concentration, cell number, reaction volumes, incubation duration, lytic buffer composition and fluorophore-coupled antibody concentration. In order to minimize effects of temperature-induced gradients observed in cell-based 
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screens (26), we implemented a media removal step at 72 h (see Methods). We found that the incorporation of this step strongly reduced replicate variability ( Figure S3 ). This observation indicated that pre-media removal artifacts had primarily resulted from volumetric well-to-well disparities. No systemic intra-or inter-plate gradients were observed for any screen. However, plate-well series plots assessing row effects revealed small, albeit consistently disproportionate signals among outer, but not central control wells. Outer control wells were therefore excluded from all analyses. PRNP/Prnp-targeting siRNA positive controls and nontargeting siRNA negative controls dispersed throughout each plate served as a screening quality benchmark. U-251 MG mimic screening yielded the most pronounced separation of controls ( Figure 1B Figure S4B ) did not affect PrP C expression levels ( Figure S4C ). Notably, low CHP-212 Z-factors, stemming from high control signal variabilities, may have been imparted by cell growth saturation.
Identification of 19 Overlapping Candidate Mimics
In order to highlight differences in sample reproducibility, denoted by strictly standardized mean difference (SSMD) (47) , and biological effect sizes, denoted by log 2 fold change, among cell lines, we visualized screening data using dualflashlight plots (Figure 2A and Figure S5A ). Hit selection was performed by overlaying SSMDs from CHP-212 or SH-SY5Y M4 with U-251 MG screens. We applied SSMDs set at extremely strong cutoffs (≥5, ≤−5) for U-251 MG, and very strong cutoffs (≥3, ≤−3) (48) for CHP-212 and SH-SY5Y M4 cells. This yielded a total of 12 candidate mimics from CHP-212 screen overlaps (blue crosses) and 7 candidate mimics from SH-SY5Y M4 screen overlaps (red crosses) ( Figure 2B ). Mimic screen datasets displaying replicate Net FRET, SSMD, log 2 fold change, P-value, miRNA name and sequence are listed in Table S2 . Intersection of CHP-212 and SH-SY5Y M4 SSMDs shows that this strategy would have called only 3 out of the 19 candidates ( Figure 2C ). However, as CHP-212 produced a poor Z′ and SH-SY5Y M4 harbored no PRNP 3′UTR, we opted to utilize more reliable hit-calling strategy by contrasting screens only to U-251 MG.
Inhibitor screening on the other hand, produced no overlaps between cell lines, even when setting low SSMD (≥1.5, ≤−1.5) cutoff criteria ( Figure S5B ). Moreover, no inhibitor generated SSMDs ≤−3 or ≥3 in any individual cell line. Inhibitor screen datasets are shown in Table S3 .
We assessed whether the absence of inhibitor effects was due to a lack of library functionality by transfecting U-251 MG with the library-sourced let-7d-5p inhibitor, a known regulator of HMGA2 (36) . A statistically significant upregulation of HMGA2 expression was observed at all concentrations ( Figure S4A ), indicating that our inhibitor library was functional. These findings suggest a potential compensatory role in the regulation of PrP C expression by endogenous miRNAs, which could be overcome by simultaneous inhibition of all functionally redundant miRNAs. Alternatively, it is likely that U-251 MG and CHP-212 express insufficient quantities of endogenous PrP C -regulating miRNAs.
While the majority of mimics displayed consistent PrP C down-or up-regulation, three candidates exhibited divergent PrP C regulatory effects in different cell lines ( Figure 2B ). Each of these opposing effects was attributed to a mimicinduced altered cell number in a follow-up viability assessment ( Figure S6B ). For example, miR-342-5p was found to increase cell viability in U-251 MG, which contrarily may have resulted in death of the already growth saturated CHP-212 cells. In contrast, miR-148b-3p, which was found to increase viability of U-251 MG cells while simultaneously eliciting PrP C downregulation by targeting the PRNP 3′UTR could exclusively be detected in SH-SY5Y M4 when contrasted to U-251 MG ( Figure 2B ). By this standard, a majority of miRNA mimic candidates eliciting an effect on PrP C via the PRNP 3′UTR would be detectable only in U-251 MG-CHP-212 overlaps.
Hits predominantly reduce steady state PRNP mRNA levels
We first sought to determine whether the regulatory actions of our candidate mimics on PrP C were independent of any miRNA-induced alterations in cell growth. To do so, we transfected mimics into U-251 MG alongside scrambled negative-as well as cell death-inducing positive control siRNAs, and assessed changes in viability. Based on our cutoff criteria, no miRNAs decreased cell viability whereas six out of the 19 mimic candidates increased cell viability ( Figure S6B ). However, out of these 6 mimics only miR-342-5p and miR-4802-5p displayed a concomitant PrP C increase ( Figure S6A ). These two mimic candidates are therefore likely to increase PrP C levels due to increased cell viability. The remaining 17 mimics were considered high-confidence hits regulating PrP C independently of cell count.
In order to assess whether hits elicited translational repression or mRNA degradation, we assessed steady-state PRNP mRNA levels. RNA was extracted at the same 72 h time point at which we measured PrP C protein levels, as miRNA-target interactions often initially result in translational repression followed by mRNA degradation (6). All but three hits were found to down-regulate PRNP mRNA ( Figure S6C) . Moreover, the degree of mRNA regulation correlated strongly with the degree of protein regulation (R 2 : 0.679) for all candidate mimics (Figure 3) , suggesting that the majority of hits function either directly via degradation of PRNP mRNA or indirectly via transcriptional regulation. miR-124-3p, miR-192-3p and miR-299-5p altered PrP C protein but not PRNP mRNA levels, indicating that these hits regulate PrP C either by inhibiting/ activating PRNP translation directly, or by regulating a PrP C interactor.
miRNA Target Sites Abundant in PRNP 3′UTR
To determine whether the miRNAs identified by our screen regulate PrP C in a direct or indirect manner, we examined TargetScan7.2 (www.targetscan.org) predicted miRNA target sites within the PRNP 3′UTR (Table 1) . Of the 13 predicted miRNAs with broadly conserved sites, three miRNAs, namely miR-148a-3p, miR-148b-3p and miR-152-3p were among our hits. Additionally, of 447 miRNAs with poorly conserved sites a further nine hits, namely miR20b-5p, miR-188-3p, miR-338-5p, miR-519d-3p, miR-4686, miR-5588-3p, miR-193a-3p, miR-193b-3p and miR-519b-3p were predicted to bind the PRNP 3′UTR. Two screening hits, namely miR-371a-3p and miR-376b-3p that were not predicted to harbor binding sites in the 3′UTR, did however have closely related family members miR-371b-3p and miR-376c-3p that were predicted to possess poorly conserved target sites therein. Interestingly, none of the miRNAs that induced discordant changes in steady state mRNA and PrP C protein levels had a predicted binding site in the PRNP 3′UTR. We further examined CLIP datasets for putative miRNA binding sites of all hits (Table 1) . These further confirmed the absence of target sites for either miR-124-3p or miR-192-3p, but indicated binding of miR-299-5p to the PRNP CDS. Overall 14 miRNAs are predicted to bind the PRNP 3′UTR by targeting 9 sequences.
In order to confirm putative miRNA target sites and validate a miRNA-mediated regulation of protein expression through these sites, we utilized a common dual-luciferase reporter assay. The wild type (wt) or mutant 3′UTR or wt CDS of PRNP was cloned downstream of the Firefly luciferase CDS. After normalization with Renilla luciferase, which acts as an internal control, the Firefly luciferase signal acts as a proxy for miRNA function. Plasmids harboring the full-length wt PRNP 3′UTR, 9 mutant forms thereof (Table  S1 ), or the full-length PRNP CDS were co-transfected into HEK-293T with respective mimics.
miR-148a-3p, miR-148b-3p and miR-152-3p, only had a minor or no significant effect on the wt PRNP 3′UTR reporter (Figure 4) , despite CLIP data indicating that these miRNAs bind the PRNP 3′UTR (3, 9) . However, when co-transfecting these mimics with their respective mutant reporter, we observed significant signal increases relative to the wt 3′UTR reporter. Differences in wt and mutant reporters were only observed in the presence of mimics, suggesting that these three miRNA directly regulate the PRNP 3′UTR. Notably, sequence alignment using Clustal Omega (www.ebi.ac.uk) revealed that all three of these miRNAs are partially complementary to the Renilla luciferase CDS, potentially accounting for the lack of effect observed in the wt PRNP 3′UTR reporter. miR-20b-5p, miR-188-3p, miR-338-5p, miR371a-3p, miR-519d-3p, miR-519b-3p, miR-4686, miR193a-3p, miR-193b-3p and miR-5588-3p all elicited a significant signal reduction when co-transfected with the wt PRNP 3′UTR reporter. Moreover, these effects were mitigated when the wt 3′UTR construct was replaced with respective mutant reporters for all but miR-5588-3p, thereby confirming that 12 out of the 14 predicted sites are functional targets for miRNA-mediated PrP C downregulation. It is feasible that the miR-5588-3p-induced effect could not be inhibited when co-transfecting this mimic with its mutant reporter construct due to an additional unpredicted 3′UTR target site.
Although miR-371a-3p and miR-376b-3p were only derivatively predicted to bind the PRNP 3′UTR, we assessed whether they could evoke an effect via the wt 3′UTR reporter. We found that miR-371a-3p significantly regulated the PRNP 3′UTR reporter in a site-specific manner, whereas miR-376b-3p had no effect. The lack of miR-376b-3p-mediated regulation may be due to its altered seed region sequence relative to miR-376c-3p, which was predicted to bind the PRNP 3′UTR. We also examined whether miR-124-3p, miR-192-3p or miR-299-5p could elicit an effect via either the PRNP 3′UTR or the CDS, but found that none of these mimics significantly regulated either the wt 3′UTR or CDS reporter (Figure 4 ). In conclusion, our reporter assays revealed that 13 out of the 17 screening hits had functional target sites within the PRNP 3′UTR, while the remaining 4 PrP C regulators could not be confirmed to regulate PRNP in a direct manner (summarized in Table 2 ).
DISCUSSION
The current study exhaustively explores and validates functional roles of PrP C -regulating miRNAs. This was accomplished by developing a robust high-throughput arrayed screening platform that assessed direct and indirect effects of the human miRNAome on PrP C levels. Selection of a suitable cell line that produces reproducible results, as revealed by control-derived Z′-Factors, is a prerequisite for successful screening. We detected 17 high-confidence miRNA mimic hits, 13 of which were found to function directly by binding to the PRNP 3′UTR and induce transcript degradation. Crucially, the degree to which miRNA mimics regulated PrP C protein correlated well (R 2 : 0.679) with the degree of PRNP mRNA expression change (Figure 3) . These results are consistent with the observation that 66%-90% miRNA-mediated repression can be attributed to mRNA destabilization (15) .
Hit-induced PrP C reduction found in U-251 MG and CHP-212 was not generally reflected in SH-SY5Y M4 cells (Table 2 ). This was expected for miRNAs acting through the PRNP 3′UTR, which is not present in SH-SY5Y M4. An exception were miR-193a-3p and miR-193b-3p, which displayed decreased PrP C levels in all three cell lines. This suggests that these miRNAs may induce PrP C regulation through multiple pathways.
Four of our hits could not be confirmed to regulate PRNP via its 3′UTR or CDS and were therefore deemed indirect regulators of PrP C expression. Owing to the high number of miRNA targets that may function as single intermediary interactors or in complex regulatory cascades, it would be challenging to identify such indirect regulatory pathways. However, based on the unchanged PRNP mRNA but significantly altered PrP C protein levels upon transfection with miR-124-3p, miR-192-3p or miR-299-5p mimics, we speculate that these three miRNAs may function by regulating PrP C protein stability and/or turnover. Conversely, miR-376b-3p, which was found to decrease both mRNA and protein levels, may possibly function by targeting a PRNP-regulating transcription factor. As PrP C is essential for scrapie-induced neurotoxicity (10) , and the depletion of neuronal PrP C is known to prevent disease and reverse accompanying pathognomonic spongiosis occurring during prion infection (28) , reduction or depletion of endogenous PrP C might constitute a therapeutic option for TSEs. Moreover, as conditional post-natal knockout (29) or complete ablation (34) of PrP C results in relatively mild phenotypes (2, 11) , the modulation of PrP C levels does in fact represent a compelling therapeutic approach. Notably, the pleiotropic nature of miRNAs provides them with one important therapeutic advantage over siRNAs, as it enables single miRNAs to modulate multiple possibly disease-linked pathways in complex multigenic conditions. 
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Applying miRNA functional information to expression datasets has the potential to uncover novel miRNAregulated pathways that may play important, if not causal, roles in disease. miR-124-3p, one of the most abundant miRNAs in the brain, is known to be deregulated in multiple CNS disorders (44) . In prion disease specifically, miR-124-3p has been shown to become significantly upregulated in mouse hippocampal CA1 neurons at 70 and 90 days post scrapie infection, while contrarily becoming downregulated at 130 and 160 days post infection (27) . In human post-mortem sCJD frontal cortical and cerebellar samples, miR-124-3p was similarly found to be decreased relative to control tissues (23) . This conserved temporal regulation in miR-124-3p expression indicates a potential role of this miRNA in prion disease pathology.
Both miR-148a-3p and 148b-3p are highly expressed in the human brain (35) . These two mimic hits elicited the strongest down-regulatory effect on PrP C protein and PRNP mRNA levels (Figure 3) , indicating that these miRNAs may mediate endogenous suppression of the prion protein in healthy brains. However, neither of these miRNAs has been found to be deregulated during prion infection.
The current study marks the first to discover a functional indirect regulatory role of miR-124-3p on PrP C expression levels. No other screening hit except for miR-124-3p has been documented as being consistently altered during prion disease. miR-146a-5p and miR-342-3p, which have been found to be deregulated in multiple TSEs (25, 33, 40, 41) , had no effect on PrP C expression levels.
There is a growing consensus that modulation of PrP C may represent the most realistic therapeutic approach for treatment of prion diseases, which may have particular prophylactic value for genetic PRNP mutation carriers (32) . Furthermore, as the depletion of PrP C has been found to cause demyelination in the peripheral nervous system (11) through reduced excitation of its receptor Gpr126 (20) , these considerations highlight the importance of elucidating PrP C -regulatory mechanisms in physiological conditions. In-depth investigations, not only of animal models but also observational studies in human cohorts are warranted. The ultimate goal of such studies would be to test whether manipulation of the miRNA landscape, or its downstream effectors in the case of indirectly acting miRNAs, might be pharmacologically exploitable for the treatment of patients at risk of prion diseases.
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